NVP-BSK805 2HCl is a potent, selective, ATP-competitive JAK2 inhibitor (IC50 = 0.5 nM), exhibiting >20-fold selectivity over JAK1, JAK3, and TYK2; it induces apoptosis in JAK2-dependent cells (e.g., SET-2 and MB-02) through activation of the caspase cascade, and shows oral bioavailability of approximately 45% in mice and 50% in rats.